TORY FOSS: Open Payments
NPI 1881086379 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 82 payments from 14 companies in 2025. Trend: 2023 $2,592 · 2024 $2,078 · 2025 $1,632
Food & beverage: $1,622Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $429 |
| Janssen Biotech, Inc. | 15 | $267 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $194 |
| GENZYME CORPORATION | 6 | $158 |
| PFIZER INC. | 5 | $124 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $97 |
| Lilly USA, LLC | 4 | $90 |
| Arcutis Biotherapeutics, Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| UCB, Inc. | 2 | $56 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, ILUMYA, CIBINQO, SILIQ, TALTZ.
Industry payments across WA — which companies pay providers there.
